Similar articles for PMID: 29444992

Year	Number of Results
1971	1
1975	1
1985	2
1989	1
1990	4
1991	1
1992	3
1993	3
1994	2
1995	1
1996	9
1997	3
1998	1
1999	3
2000	3
2001	2
2002	2
2003	4
2004	4
2005	8
2006	7
2007	2
2008	3
2009	7
2010	4
2011	2
2012	4
2013	4
2014	4
2015	8
2016	5
2017	8
2018	13
2019	11
2020	6
2021	3
2022	3
2024	0

1

Microbiological Control for Affinity Capture Chromatography Processing: An Industry Perspective.

Murphy M, Bell BL, Moshi J, Grassi R, Forng RY, Salaman A, Jordi PW, Zaidi S, Goodnight M, Paul M, Keller A, Carpenter B, Hearty U, Willison-Parry D. Murphy M, et al. PDA J Pharm Sci Technol. 2018 Mar-Apr;72(2):213-221. doi: 10.5731/pdajpst.2017.008045. Epub 2018 Feb 14. PDA J Pharm Sci Technol. 2018. PMID: 29444992

2

Risk reduction in biotherapeutic products.

Ill CR, Dehghani H. Ill CR, et al. Curr Opin Drug Discov Devel. 2009 Mar;12(2):296-304. Curr Opin Drug Discov Devel. 2009. PMID: 19333875 Review.

3

Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.

Page T, Dubina H, Fillipi G, Guidat R, Patnaik S, Poechlauer P, Shering P, Guinn M, Mcdonnell P, Johnston C. Page T, et al. J Pharm Sci. 2015 Mar;104(3):821-31. doi: 10.1002/jps.24282. Epub 2014 Dec 1. J Pharm Sci. 2015. PMID: 25448273 Review.

4

Aseptic processing contamination case studies and the pharmaceutical quality system.

Friedman RL. Friedman RL. PDA J Pharm Sci Technol. 2005 Mar-Apr;59(2):118-26. PDA J Pharm Sci Technol. 2005. PMID: 15971544

5

Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing.

Barone PW, Avgerinos S, Ballard R, Brussel A, Clark P, Dowd C, Gerentes L, Hart I, Keumurian FJ, Kindermann J, Leung JC, Ly N, Mink S, Minning S, Mullberg J, Murphy M, Nöske K, Parriott S, Shum B, Wiebe ME, Springs SL. Barone PW, et al. PDA J Pharm Sci Technol. 2019 Mar-Apr;73(2):191-203. doi: 10.5731/pdajpst.2018.008862. Epub 2018 Oct 25. PDA J Pharm Sci Technol. 2019. PMID: 30361281

6

[Microbiological in-process control in drug manufacture].

Seyfarth VH. Seyfarth VH. Arzneimittelforschung. 1985;35(1A):205-16. Arzneimittelforschung. 1985. PMID: 4039162 German.

7

Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective.

Kozak RW, Golker CF, Stadler P. Kozak RW, et al. Dev Biol Stand. 1996;88:257-64. Dev Biol Stand. 1996. PMID: 9119148

8

Viability-based rapid microbiological methods for sterility testing and the need for identification of contamination.

Moldenhauer J. Moldenhauer J. PDA J Pharm Sci Technol. 2006 Mar-Apr;60(2):81-8. PDA J Pharm Sci Technol. 2006. PMID: 16696190 No abstract available.

9

Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.

Allison G, Cain YT, Cooney C, Garcia T, Bizjak TG, Holte O, Jagota N, Komas B, Korakianiti E, Kourti D, Madurawe R, Morefield E, Montgomery F, Nasr M, Randolph W, Robert JL, Rudd D, Zezza D. Allison G, et al. J Pharm Sci. 2015 Mar;104(3):803-12. J Pharm Sci. 2015. PMID: 25830179 Review.

10

Container Closure Integrity Testing-Practical Aspects and Approaches in the Pharmaceutical Industry.

Brown H, Mahler HC, Mellman J, Nieto A, Wagner D, Schaar M, Mathaes R, Kossinna J, Schmitting F, Dreher S, Roehl H, Hemminger M, Wuchner K. Brown H, et al. PDA J Pharm Sci Technol. 2017 Mar-Apr;71(2):147-162. doi: 10.5731/pdajpst.2016.006999. Epub 2016 Oct 27. PDA J Pharm Sci Technol. 2017. PMID: 27789803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

137 results

Results by year